ArticleCurrent oncology (Toronto, Ont.)2026

Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.

Sruthi P Ramanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.